783 related articles for article (PubMed ID: 7612054)
21. Histamine and growth: interaction of antiestrogen binding site ligands with a novel histamine site that may be associated with calcium channels.
Brandes LJ; Bogdanovic RP; Cawker MD; LaBella FS
Cancer Res; 1987 Aug; 47(15):4025-31. PubMed ID: 2886214
[TBL] [Abstract][Full Text] [Related]
22. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of histamine H1-receptors in peripheral tissues labeled with [3H]mepyramine.
Chang RS; Tran VT; Snyder SH
J Pharmacol Exp Ther; 1979 Jun; 209(3):437-42. PubMed ID: 108389
[TBL] [Abstract][Full Text] [Related]
24. Identification and characterization of histamine H1- and H2-receptors in guinea-pig left atrial membranes by [3H]-mepyramine and [3H]-tiotidine binding.
Hattori Y; Endou M; Gando S; Kanno M
Br J Pharmacol; 1991 Jun; 103(2):1573-9. PubMed ID: 1909203
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of the antihistamine effect of TAK-427, a novel imidazopyridazine derivative.
Fukuda S; Midoro K; Yamasaki M; Gyoten M; Kawano Y; Fukui H; Ashida Y; Nagaya H
Inflamm Res; 2003 May; 52(5):206-14. PubMed ID: 12813625
[TBL] [Abstract][Full Text] [Related]
26. Effects of impromidine- and arpromidine-derived guanidines on recombinant human and guinea pig histamine H1 and H2 receptors.
Xie SX; Schalkhausser F; Ye QZ; Seifert R; Buschauer A
Arch Pharm (Weinheim); 2007 Jan; 340(1):9-16. PubMed ID: 17206612
[TBL] [Abstract][Full Text] [Related]
27. Nicotine is a competitive antagonist for H1-receptors in smooth muscles.
Ercan ZS; Türker RK
Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):24-30. PubMed ID: 2861794
[TBL] [Abstract][Full Text] [Related]
28. Preclinical pharmacology of bilastine, a new selective histamine H1 receptor antagonist: receptor selectivity and in vitro antihistaminic activity.
Corcóstegui R; Labeaga L; Innerárity A; Berisa A; Orjales A
Drugs R D; 2005; 6(6):371-84. PubMed ID: 16274260
[TBL] [Abstract][Full Text] [Related]
29. Characterization of thromboxane A2/prostaglandin H2 receptors and histamine H1 receptors in cultured guinea-pig tracheal smooth-muscle cells.
Miki I; Nonaka H; Ishii A
Biochim Biophys Acta; 1992 Oct; 1137(1):107-15. PubMed ID: 1356444
[TBL] [Abstract][Full Text] [Related]
30. [3H]Mianserin: differential labeling of serotonin and histamine receptors in rat brain.
Peroutka SJ; Snyder SH
J Pharmacol Exp Ther; 1981 Jan; 216(1):142-8. PubMed ID: 6109019
[TBL] [Abstract][Full Text] [Related]
31. Role of the histamine system in nefopam-induced antinociception in mice.
Girard P; Pansart Y; Coppé MC; Verniers D; Gillardin JM
Eur J Pharmacol; 2004 Oct; 503(1-3):63-9. PubMed ID: 15496297
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the antinociceptive properties of cimetidine and a structural analog.
Li BY; Nalwalk JW; Barker LA; Cumming P; Parsons ME; Hough LB
J Pharmacol Exp Ther; 1996 Feb; 276(2):500-8. PubMed ID: 8632315
[TBL] [Abstract][Full Text] [Related]
33. Characterization of histamine H1 binding sites on human T lymphocytes by means of 125I-iodobolpyramine. Preferential expression of H1 receptors on CD8 T lymphocytes.
Villemain FM; Bach JF; Chatenoud LM
J Immunol; 1990 Feb; 144(4):1449-54. PubMed ID: 1968079
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.
Sharif NA; Xu SX; Miller ST; Gamache DA; Yanni JM
J Pharmacol Exp Ther; 1996 Sep; 278(3):1252-61. PubMed ID: 8819509
[TBL] [Abstract][Full Text] [Related]
35. Studies on the novel antiallergic agent HSR-609: its penetration into the central nervous system in mice and guinea pigs and its selectivity for the histamine H1-receptor.
Kakiuchi M; Ohashi T; Musoh K; Kawamura K; Morikawa K; Kato H
Jpn J Pharmacol; 1997 Apr; 73(4):291-8. PubMed ID: 9165365
[TBL] [Abstract][Full Text] [Related]
36. Temperature dependence of the binding of [3H]mepyramine and related compounds to the histamine H1 receptor.
Wallace RM; Young JM
Mol Pharmacol; 1983 Jan; 23(1):60-6. PubMed ID: 6135145
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological properties of cardiovascular histamine H1 receptor binding sites: characterisation with 2-phenylhistamines.
Carman-Krzan M; Krzan M; Schunack W
Naunyn Schmiedebergs Arch Pharmacol; 1997 Apr; 355(4):431-7. PubMed ID: 9109357
[TBL] [Abstract][Full Text] [Related]
38. Histamine-induced inositol phospholipid breakdown in the longitudinal smooth muscle of guinea-pig ileum.
Donaldson J; Hill SJ
Br J Pharmacol; 1985 Jun; 85(2):499-512. PubMed ID: 2992666
[TBL] [Abstract][Full Text] [Related]
39. Dissociation between central and peripheral antihistamine activities of the new antiallergic agent N-[4-[4-(diphenylmethyl)-1-piperazinyl]-butyl]-3-(6-methyl-3-pyridyl) acrylamide in rats and monkeys.
Ishii K; Yakuo I; Nakagawa H; Nakamura H
Arzneimittelforschung; 1993 Jun; 43(6):668-71. PubMed ID: 8102529
[TBL] [Abstract][Full Text] [Related]
40. Affinities of histamine H1-antagonists in guinea pig brain: similarity of values determined from [3H]mepyramine binding and from inhibition of a functional response.
Hill SJ; Daum P; Young JM
J Neurochem; 1981 Nov; 37(5):1357-60. PubMed ID: 6117608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
